Federal Register / Vol. 71, No. 22 / Thursday, February 2, 2006 / Notices 5675 

fulfill the purpose and need to provide 

national biocontainment facilities. Other 

relevant factors included in the 

decision, such as NIAID’s mandate to 

conduct and support research on agents 

of emerging and re-emerging infectious 

diseases, were carefully considered. 

Dated: January 26, 2006. 

Juanita M. Mildenberg, 

FAIA Acting Director, Office of Research 

Facilities Development and Operations, 

National Institutes of Health. 

[FR Doc. E6–1402 Filed 2–1–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting: Secretary’s 

Advisory Committee on Genetics, 

Health, and Society 

Pursuant to Public Law 92–463, 

notice if hereby given of the ninth 

meeting of the Secretary’s Advisory 

Committee on Genetics, Health, and 

Society (SACGHS), U.S. Public Health 

Service. The meeting will be held from 

9 a.m. to 5 p.m. on March 27, 2006 and 

9 a.m. to 5 p.m. on March 28, 2006 at 

the National Institutes of Health, 

Building 31, C Wing, Conference Room 

6, 31 Center Drive, Bethesda, MD 20892. 

The meeting will be open to the public 

with attendance limited to space 

available. The meeting will be webcast. 

The first day of the meeting will 

include sessions on pharmacogenomics 

and large population studies of genetic 

variation, the environment and common 

disease. The pharmacogenomics session 

will include a review of Federal efforts 

in pharmacogenomics and deliberation 

on draft recommendations in this area. 

The large population studies session 

will involve discussion of a draft report 

that identifies policy issues associated 

with mounting a large population study 

in the United States. 

The second day will be devoted to 

sessions on genetic discrimination and 

patents and licensing issues. The 

genetic discrimination session will 

include an update on the status of 

Federal genetic non-discrimination 

legislation. The patents and licensing 

session will involve a presentation on 

the findings and conclusions of a 

National Academy of Sciences’ report 

on intellectual property rights in 

genomic research and innovation, and a 

discussion on whether there are other 

issues in this arena that warrant 

SACGHS’s further attention. 

Time will be provided each day for 

public comments. The Committee 

would welcome hearing from anyone 

wishing to provide public comment on 

any issue related to genetics, health and 

society. Individuals who would like to 

provide public comment or who plan to 

attend the meeting and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

SACGHS Executive Secretary, Ms. Sarah 

Carr, by telephone at 301–496–9838 or 

e-mail at sc112@nih.gov. The SACGHS 

office is located at 6705 Rockledge 

Drive, Suite 750, Bethesda, MD 20892. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

technologies and, as warranted, to 

provide advice on these issues. The 

draft meeting agenda and other 

information about SACGHS, including 

information about access to the webcast 

will be available at the following Web 

site: http://www4.od.nih.gov/oba/ 

sacghs.htm. 

Dated: January 26, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–979 Filed 2–1–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting: Secretary’s 

Advisory Committee on Genetics, 

Health, and Society 

Pursuant to Public Law 92–463, 

notice is hereby given of the ninth 

meeting of the Secretary’s Advisory 

Committee on Genetics, Health, and 

Society (SACGHS), U.S. Public Health 

Service. The meeting will be held from 

9 a.m. to 5 p.m. on March 27, 2006 and 

9 a.m. to 5 p.m. on March 28, 2006 at 

the National Institutes of Health, 

Building 31, C Wing, Conference Room 

6, 31 Center Drive, Bethesda, MD 20892. 

The meeting will be open to the public 

with attendance limited to space 

available. The meeting will be webcast. 

The first day of the meeting will 

include sessions on pharmacogenomics 

and large population studies of genetic 

variation, the environment and common 

disease. The pharmacogenomics session 

will include a review of Federal efforts 

in pharmacogenomics and deliberation 

on draft recommendations in this area. 

The large population studies session 

will involve discussion of a draft report 

that identifies policy issues associated 

with mounting a large population study 

in the United States. 

The second day will be devoted to 

sessions on genetic discrimination and 

patents and licensing issues. The 

genetic discrimination session will 

include an update on the status of 

Federal genetic non-discrimination 

legislation. The patents and licensing 

session will involve a presentation on 

the findings and conclusions of a 

National Academy of Sciences report on 

intellectual property rights in genomic 

research and innovation, and a 

discussion of whether there are other 

issues in this area that warrant 

SACGHS’s further attention. 

Time will be provided each day for 

public comments. The Committee 

would welcome hearing from anyone 

wishing to provide public comment on 

any issue related to genetics, health and 

society. Individuals who would like to 

provide public comment or who plan to 

attend the meeting and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodation, should notify the 

SACGHS Executive Secretary, Ms. Sarah 

Carr, by telephone at 301–496–9838 or 

e-mail at sc112c@nih.gov. The SACGHS 

office is located at 6705 Rockledge 

Drive, Suite 750, Bethesda, MD 20892. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

technologies and, as warranted, to 

provide advice on these issues. The 

draft meeting agenda and other 

information about SACGHS, including 

information about access to the webcast 

will be available at the following Web 

site: http://www4.od.nih.gov/oba/ 

sacghs.htm. 

Dated: January 26, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–978 Filed 2–1–06; 8:45 am] 

BILLING CODE 4140–01–M 


hsrobinson on PROD1PC71 with NOTICES